Clinical Trial Update: Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis

View source ↗

Summary

A clinical trial evaluating glucocorticoid-induced osteoporosis in patients with chronic inflammatory rheumatic diseases or psoriasis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Rheumatic Diseases
• Osteoporosis
• Psoriasis

Snippet

Sponsor: Prof Dr Frank Buttgereit | Conditions: Osteoporosis, Inflammatory Rheumatism | Status: RECRUITING